Methods for the Economic Evaluation of Health Care Programmes
Oxford University Press, 2005 - Medical - 379 pages
The highly successful textbook Methods for the Economic Evaluation of Health Care is now available in its third edition. Over the years it has become the standard textbook in the field world-wide. It mirrors the huge expansion of the field of economic evaluation in health care.
This new edition builds on the strengths of previous editions being clearly written in a style accessible to a wide readership. Key methodological principles are outlined using a critical appraisal checklist that can be applied to any published study. The methodological features of the basic forms of analysis are then explained in more detail with special emphasis of the latest views on productivity costs, the characterization of uncertainty and the concept of net benefit. The book has been greatly revised and expanded especially concerning analyzing patient-level data and decision-analytic modeling. There is discussion of new methodological approaches, including cost effectiveness acceptability curves, net benefit regression, probalistic sensitivity analysis and value of information analysis. There is an expanded chapter on the use of economic evaluation, including discussion of the use of cost-effectiveness thresholds, equity considerations and the transferability of economic data.
This new edition is required for anyone commissioning, undertaking or using economic evaluations in health care, and will be popular with health service professionals, health economists, pharmacists and health care decision makers. It is especially relevant for those taking pharmacoeconomics courses.
What people are saying - Write a review
How to use this book
Basic types of economic evaluation
Critical assessment of economic evaluation
Other editions - View all
additional adjusted allocation alternative analysis applied approach appropriate assess assumed assumptions attributes benefits calculated changes Chapter choice clinical compared comparison condition considered cost-effectiveness costs costs and consequences countries death decision decision-making depends described developed discount discussed disease drug economic evaluation effects estimates et al evidence example existing expected future gained given health care Health Economics hospital important incremental individual interest interval intervention issues Journal life-years limitations mean measure Medical methods myocardial infarction options outcomes parameters particular patients possible practice preference present probability problem productivity programme QALY question randomized ratio reduce relative relevant represent risk savings scale scores sensitivity setting specific standard statistical Table Test theory therapy threshold Torrance treatment trial types uncertainty unit utility valuation vary weights
All Book Search results »